| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Section on Cellular and Molecular Physiology (J.D., B.-H.Q., D.L.), Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases; Cancer Genetics Branch (J.K., P.M.), National Human Genome Research Institute, National Cancer Institute, Molecular Regulation; and Molecular Oncology Section (L.H.), Pediatric Oncology Branch, NIH, Bethesda, Maryland 20892-1758
Address all correspondence and requests for reprints to: Derek LeRoith, M.D., Ph.D., Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Room 8D12, Building 10, NIH, Bethesda, Maryland 20892-1758. E-mail: derek{at}helix.nih.gov
The IGF-1 receptor and the related insulin receptor are similar in structure and activate many of the same postreceptor signaling pathways, yet they mediate distinct biological functions. It is still not understood how the specificity of insulin vs. IGF-1 signaling is controlled. In this study, we have used cDNA microarrays to monitor the gene expression patterns that are regulated by insulin and IGF-1. Mouse fibroblast NIH-3T3 cells expressing either the wild-type human IGF receptor or the insulin receptor were stimulated with either IGF-1 or insulin, respectively. Thirty genes, 27 of which were not previously known to be IGF-1 responsive, were up-regulated by IGF-1 but not by insulin. Nine genes, none of which was previously known to be insulin responsive, were up-regulated by insulin but not by IGF-1. The IGF- and insulin-induced regulation of 10 of these genes was confirmed by Northern blot analysis. Interestingly, more than half of the genes up-regulated by IGF-1 are associated with mitogenesis and differentiation, whereas none of the genes specifically up-regulated by insulin are associated with these processes. Our results indicate that under the conditions used in this study, IGF-1 is a more potent activator of the mitogenic pathway than insulin in mouse fibroblast NIH-3T3 cells.
This article has been cited by other articles:
![]() |
L. Yu, J. E. Coelho, X. Zhang, Y. Fu, A. Tillman, U. Karaoz, B. B. Fredholm, Z. Weng, and J.-F. Chen Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling Physiol Genomics, May 13, 2009; 37(3): 199 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pacher, M. J. Seewald, M. Mikula, S. Oehler, M. Mogg, U. Vinatzer, A. Eger, N. Schweifer, R. Varecka, W. Sommergruber, et al. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells Carcinogenesis, January 1, 2007; 28(1): 49 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huo, G. Fu, X. Wang, W. K. W. Ko, and A. O. L. Wong Modulation of Calmodulin Gene Expression as a Novel Mechanism for Growth Hormone Feedback Control by Insulin-like Growth Factor in Grass Carp Pituitary Cells Endocrinology, September 1, 2005; 146(9): 3821 - 3835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Toyoshima, M. Karas, S. Yakar, J. Dupont, Lee Helman, and D. LeRoith TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival J. Biol. Chem., June 11, 2004; 279(24): 25898 - 25904. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pandini, E. Medico, E. Conte, L. Sciacca, R. Vigneri, and A. Belfiore Differential Gene Expression Induced by Insulin and Insulin-like Growth Factor-II through the Insulin Receptor Isoform A J. Biol. Chem., October 24, 2003; 278(43): 42178 - 42189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dupont, S. E. Dunn, J. C. Barrett, and D. LeRoith Microarray Analysis and Identification of Novel Molecules Involved in Insulin-like Growth Factor-1 Receptor Signaling and Gene Expression Recent Prog. Horm. Res., January 1, 2003; 58(1): 325 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mulligan, J. Rochford, G. Denyer, R. Stephens, G. Yeo, T. Freeman, K. Siddle, and S. O'Rahilly Microarray Analysis of Insulin and Insulin-like Growth Factor-1 (IGF-1) Receptor Signaling Reveals the Selective Up-regulation of the Mitogen Heparin-binding EGF-like Growth Factor by IGF-1 J. Biol. Chem., November 1, 2002; 277(45): 42480 - 42487. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Urban and Y. Bodenburg PTB-associated splicing factor regulates growth factor-stimulated gene expression in mammalian cells Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E794 - E798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Afshari Perspective: Microarray Technology, Seeing More Than Spots Endocrinology, June 1, 2002; 143(6): 1983 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soulet and S. Rivest Perspective: How to Make Microarray, Serial Analysis of Gene Expression, and Proteomic Relevant to Day-to-Day Endocrine Problems and Physiological Systems Endocrinology, June 1, 2002; 143(6): 1995 - 2001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |